nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic
|
Cohen, Joseph R. |
|
|
41 |
4 |
p. 651-672 |
artikel |
2 |
A Hollow Microneedle Equipped with a Micropillar for Improved Needle Insertion and Injection of Drug Solution
|
Futaki, Mika |
|
|
41 |
4 |
p. 819-831 |
artikel |
3 |
Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects
|
Dang, Xiangnan |
|
|
41 |
4 |
p. 751-763 |
artikel |
4 |
Evaluation of Pharmacokinetic and Pharmacodynamic (PK/PD) of Novel Fluorenylmethoxycarbonyl- Phenylalanine Antimicrobial Agent
|
Gahane, Avinash Y. |
|
|
41 |
4 |
p. 687-698 |
artikel |
5 |
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework
|
Romagnoli, Alessia |
|
|
41 |
4 |
p. 721-730 |
artikel |
6 |
Identification of Surfactant Impact on a Monoclonal Antibody Characterization via HPLC-Separation Based and Biophysical Methods
|
Guo, Kaizhu |
|
|
41 |
4 |
p. 779-793 |
artikel |
7 |
Importance of Considering Fed-State Gastrointestinal Physiology in Predicting the Reabsorption of Enterohepatic Circulation of Drugs
|
Nakamura, Kohei |
|
|
41 |
4 |
p. 673-685 |
artikel |
8 |
Intravitreal Delivery of PEGylated-ECO Plasmid DNA Nanoparticles for Gene Therapy of Stargardt Disease
|
Sun, Da |
|
|
41 |
4 |
p. 807-817 |
artikel |
9 |
Peptide Acylation in Aliphatic Polyesters: a Review of Mechanisms and Inhibition Strategies
|
Sheikhi, Mojgan |
|
|
41 |
4 |
p. 765-778 |
artikel |
10 |
Pharmacokinetic Profile of Brepocitinib with Topical Administration in Atopic Dermatitis and Psoriasis Populations: Strategy to Inform Clinical Trial Design in Adult and Pediatric Populations
|
Maleki, Farzaneh |
|
|
41 |
4 |
p. 623-636 |
artikel |
11 |
Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia
|
Brigitha, Leiah J. |
|
|
41 |
4 |
p. 711-720 |
artikel |
12 |
Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms
|
Shen, Chaozhuang |
|
|
41 |
4 |
p. 731-749 |
artikel |
13 |
Predicting Drug-Drug Interactions Involving Rifampicin Using a Semi-mechanistic Hepatic Compartmental Model
|
Li, Jingxi |
|
|
41 |
4 |
p. 699-709 |
artikel |
14 |
Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850)
|
Kimura, Toshifumi |
|
|
41 |
4 |
p. 795-806 |
artikel |
15 |
Research Landscape of Physiologically Based Pharmacokinetic Model Utilization in Different Fields: A Bibliometric Analysis (1999–2023)
|
Wang, Xin |
|
|
41 |
4 |
p. 609-622 |
artikel |
16 |
When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?
|
Wu, Yunjiao |
|
|
41 |
4 |
p. 637-649 |
artikel |